Peripapillary Intravitreal Injection Improves AAV-Mediated Retinal Transduction
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy - Methods & Clinical Development
- Vol. 17, 647-656
- https://doi.org/10.1016/j.omtm.2020.03.018
Abstract
No abstract availableFunding Information
- Korea Health Technology R&D project
- Korea Health Industry Development Institute
- Ministry of Health and Welfare (HI17C0966)
- National Research Foundation of Korea
- Ministry of Science and ICT (2019R1A2C1005055)
This publication has 64 references indexed in Scilit:
- Immunology of AAV-Mediated Gene Transfer in the EyeFrontiers in Immunology, 2013
- Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 MutationsJAMA Ophthalmology, 2012
- Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular DegenerationMolecular Therapy, 2011
- Transduction of the inner mouse retina using AAVrh8 and AAVrh10 via intravitreal injectionExperimental Eye Research, 2010
- EXPERIMENTAL MODEL OF INTRAVITREAL INJECTION TECHNIQUESRetina, 2010
- Inner Limiting Membrane Barriers to AAV-mediated Retinal Transduction From the VitreousMolecular Therapy, 2009
- A Novel Adeno-Associated Viral Variant for Efficient and Selective Intravitreal Transduction of Rat Müller CellsPLOS ONE, 2009
- Efficiency and Safety of AAV-Mediated Gene Delivery of the Human ND4 Complex I Subunit in the Mouse Visual SystemInvestigative Ophthalmology & Visual Science, 2009
- Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kineticsProceedings of the National Academy of Sciences of the United States of America, 2008
- Long-Term Protection of Retinal Structure but Not Function Using RAAV.CNTF in Animal Models of Retinitis PigmentosaMolecular Therapy, 2001